Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus (2023)

First Author: Sy A
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0280551

PubMed Identifier: 36689413

Publication URI: http://europepmc.org/abstract/MED/36689413

Type: Journal Article/Review

Parent Publication: PLOS ONE

Issue: 1

ISSN: 1932-6203